Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
MedCap | 61MA | 22. nov 2024 | 46.45 | +4.62 |
Medesis Pharma S.A. | 76D | 22. nov 2024 | 0.35 | +5.74 |
Medexus Pharmaceuticals Inc | P731 | 22. nov 2024 | 1.38 | 0.00 |
Media and Games Invest SE | M8G | 22. nov 2024 | 3.98 | +6.84 |
Mediaco Holding Inc. - Class A | 3WX | 22. nov 2024 | 1.19 | +5.31 |
MEDIAN POLSKA S.A. ZY-,10 | GY3 | 22. nov 2024 | 0.15 | 0.00 |
Median Technologies | 4ZG | 22. nov 2024 | 3.38 | -8.77 |
Medibank Private Limited | MPV | 22. nov 2024 | 2.26 | +0.89 |
Medical Facilities Corp | 31F | 22. nov 2024 | 10.80 | +3.85 |
Medical Properties Trust Inc | M3P | 22. nov 2024 | 4.06 | +2.76 |
Mediclin AG | MED | 22. nov 2024 | 2.46 | -1.60 |
Medicover B | 5M0B | 22. nov 2024 | 14.78 | -0.14 |
Medicure Inc | NGQ1 | 22. nov 2024 | 0.60 | +2.56 |
MEDICUS PHARMA LTD. | N46 | 22. nov 2024 | 0.57 | 0.00 |
MEDICUS PHARMA LTD. | N460 | 22. nov 2024 | 2.73 | 0.00 |
MEDIFAST INC | MDF | 22. nov 2024 | 17.02 | +1.49 |
Medigene AG | MDG1 | 22. nov 2024 | 1.53 | -0.52 |
Medimi | 79T | 22. nov 2024 | 0.00 | 0.00 |
Medincell S.A. | MEB | 22. nov 2024 | 16.90 | 0.00 |
MEDIOBANCA S.P.A.UNSP.ADR | ME90 | 22. nov 2024 | 13.70 | -0.72 |
Mediobanca SpA | ME9 | 22. nov 2024 | 13.88 | -0.68 |
Medion AG | MDN | 22. nov 2024 | 14.30 | 0.00 |
Medios AG | ILM1 | 22. nov 2024 | 13.26 | -3.35 |
Medipal Holdings Corporation | 59Z | 22. nov 2024 | 15.20 | +2.01 |
Medipharm Labs Corp | MLZ | 22. nov 2024 | 0.04 | -4.07 |
Medistim | MD1 | 22. nov 2024 | 12.60 | +5.44 |
MEDIVIR AB | MVR0 | 22. nov 2024 | 0.22 | +0.93 |
MediWound Ltd. - Ordinary Shares | M8W | 22. nov 2024 | 15.80 | +1.94 |
Medley Inc. | 3YV | 22. nov 2024 | 26.40 | 0.00 |
Medmira Inc | 47M | 22. nov 2024 | 0.04 | -5.38 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.